|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-1-13
|
|
pubmed:abstractText |
Hyperthermic intraperitoneal (IP) chemotherapy after cytoreduction improves survival in patients with colorectal carcinomatosis of the peritoneal surface. Most protocols use single agents (mitomycin C or oxaliplatin) provided IP. The purpose of this study was to determine whether combination IP chemotherapy is superior to single-agent therapy in a mouse model.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil,
http://linkedlifedata.com/resource/pubmed/chemical/Leucovorin,
http://linkedlifedata.com/resource/pubmed/chemical/Mitomycin,
http://linkedlifedata.com/resource/pubmed/chemical/Organoplatinum Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Quinazolines,
http://linkedlifedata.com/resource/pubmed/chemical/cetuximab,
http://linkedlifedata.com/resource/pubmed/chemical/erlotinib,
http://linkedlifedata.com/resource/pubmed/chemical/irinotecan,
http://linkedlifedata.com/resource/pubmed/chemical/oxaliplatin,
http://linkedlifedata.com/resource/pubmed/chemical/panitumumab
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1534-4681
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
296-303
|
|
pubmed:meshHeading |
pubmed-meshheading:19707832-Animals,
pubmed-meshheading:19707832-Antibodies, Monoclonal,
pubmed-meshheading:19707832-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19707832-Camptothecin,
pubmed-meshheading:19707832-Colorectal Neoplasms,
pubmed-meshheading:19707832-Female,
pubmed-meshheading:19707832-Fluorouracil,
pubmed-meshheading:19707832-Humans,
pubmed-meshheading:19707832-Injections, Intraperitoneal,
pubmed-meshheading:19707832-Leucovorin,
pubmed-meshheading:19707832-Mice,
pubmed-meshheading:19707832-Mice, Nude,
pubmed-meshheading:19707832-Mitomycin,
pubmed-meshheading:19707832-Organoplatinum Compounds,
pubmed-meshheading:19707832-Quinazolines,
pubmed-meshheading:19707832-Survival Rate,
pubmed-meshheading:19707832-Treatment Outcome,
pubmed-meshheading:19707832-Tumor Cells, Cultured
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Combination intraperitoneal chemotherapy is superior to mitomycin C or oxaliplatin for colorectal carcinomatosis in vivo.
|
|
pubmed:affiliation |
Department of Surgery, University of Kansas Medical Center, Kansas City, KS, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
